TABLE 3.
Type of the liver disease and its complications
| Variables | Mean ± SD, median (IQR) or n (%) |
|---|---|
| Etiology of liver disease (n = 69) | |
| Alcohol cirrhosis | 27 (39%) |
| Hepatitis C cirrhosis | 12 (18%) |
| Cryptogenic cirrhosis | 10 (15%) |
| NASH cirrhosis | 8 (12%) |
| Primary biliary cirrhosis | 5 (7%) |
| Autoimmune hepatitis | 2 (3%) |
| Primary sclerosis cholangitis | 2 (3%)1 (1%) |
| Biliary cirrhosis | |
| Congenital hepatic fibrosis | 1 (1%) |
| Wilson’s disease | 1 (1%) |
| Presence of ascites (n = 68) | 50 (73%) |
| Bleeding varices (n = 68)Nonbleeding varices (n = 68) | 26 (38%)16 (23%) |
| Hepatic encephalopathy (n = 68) | 40 (58%) |
| Spontaneous bacterial peritonitis (n = 68) | 5 (7%) |
| Hepatopulmonary syndrome (n = 68) | 5 (7%) |
| Hepatorenal syndrome (n = 68) | 20 (29%) |
| History of TIPS procedure (n = 68) | 13 (19%) |
| Time from last MELD-Na score and death in mo (n = 43) (mo in median) | 0.6 (IQR, 0.3–2.0) |
| MELD-Na score closest to diagnostic RHC | 13 (IQR, 9–18) |
| MELD-Na score closest to death | 23 (IQR, 16–27) |
| OLT liver transplant listing (n = 69) | |
| Yes | 21 (30%) |
| No | 48 (70%) |
| Time from PoPH diagnosis to waitlist removal (mo) (n = 15) | 6.0 (IQR, 4.0–31.0) |
| Reasons for OLT listing removal (n = 21) | |
| Comorbidities | 5 (24%) |
| Died | 3 (14%) |
| Transplanted | 6 (29%) |
| Uncontrolled PAH | 7 (33%) |
IQR, interquartile range; MELD, model for end-stage liver disease; NASH, nonalcoholic steatohepatitis; OLT, orthotopic liver transplantation; PAH, pulmonary arterial hypertension; PoPH, portopulmonary hypertension; RHC, right heart catheterization; TIPS, transjugular intrahepatic portosystemic shunt.